Raising Biotech Finance on Volatile Public Markets: Challenge or Opportunity? (BioTuesday)  

Presentations are only available to member companies (Upgrade)
	Robert Mansfield, CEO, Neuropharm (Quoting on AIM March 2007)
	Jonathan Senior, Director, Corporate Finance, Nomura Code (Nomura Code Securities Presentation)

November's "Enterprise BioTuesday" will be focusing on raising finance on the public markets - review past, present and predicting future conditions for IPOs (for example listing and raising money on the LSE or other exchanges) as well as further placings.  In particular our financial services speaker will be asked to comment on the impact of recent market volatility on the challenge or opportunity for biotechs to raise money on the public markets.

By popular demand, OBN has adopted an excellent new networking format providing for nearly 3 hours of networking during BioTuesdays, with an earlier opportunity for nutrition and refreshments.

6:30 - 7:00 Registration

7:00 - 8:00 Networking with wine and finger buffet
8:00-8:20 Robert Mansfield, Chief Executive Officer, Neuropharm followed by Q&A
8.30-8.50 Dr. Jonathan Senior, Director, Corporate Finance, Nomura Code followed by Q&A
8:50-9:30 Networking with wine and finger buffet
9:30 pm Close

Robert Mansfield, Chief Executive Officer, Neuropharm (Confirmed)

Robert Mansfield is a CEO with very recent experience of a successful IPO raising ??20m on the LSE. Robert will share his experiences of the process, and give the audience an insight into Neuropharm's funding strategy and business model moving forward.  He will discuss challenges and opportunities, as well as potential pitfalls for biotechs raising finance on the public markets. 

Biography
Robert has extensive US and international experience of the pharmaceutical industry having held senior roles at SmithKline Beecham, in Germany, Australia and the UK. He was formerly the CEO of Vernalis Group plc., and is a past Chairman of the UK BioIndustry Association and a Fellow of the Institute of Chartered Accountants.

Robert Mansfield is responsible for the overall strategic direction of the company and for leading the Executive Management Team. He liaises with the Board, the committees of the Board and is responsible for the Investor and Press relations.

About Neuropharm (AIM : NPH.L)

Neuropharm is an international speciality pharmaceutical company whose mission is to develop and commercialise medicines for the treatment of neuro-developmental disorders.

http://www.neuropharm.co.uk/

Dr. Jonathan Senior as Director, Corporate Finance at Nomura Code Securities Ltd (Confirmed)
"Impact of increased volatility on biotech IPOs in 2008?"

Dr. Jonathan Senior has been asked to give an expert view of what the effect of increased volatility, and market fluctuations might be on IPOs and further placings by different subsectors within the life sciences sphere, especially with reference to drug development - and how market conditions have helped or hindered biotech stocks, using a a few key case studies on successful and failed biotech IPOs. Reviewing how UK biotech IPOs are performing relative to recent history, which public markets UK biotechs should be targeting, and is the current market state a precursor to a closing IPO window?

Biography
Jonathan started his career in the medical profession, Dr. Senior moved across to the financial services sector some nine years ago. In July 2007, he joined Nomura Code from Evolution Securities where he was Head of Life Sciences Equity Research. Prior to that, he was at Credit Suisse First Boston where he worked both as a member of the Healthcare Corporate Finance team and was a key member of their number one ranked Biotech Equity Research team. Jonathan has been involved in transactions for a number of Oxford-based companies including PowderJect, Oxford GlycoSciences, Oxford BioMedica.

Read more: http://codesecurities.com/contacts/senior.htm

About Nomura Code
Nomura Code has the largest and most experienced sector team in Europe, having executed over 100 life sciences financing transactions, including 37 IPOs, raising more than ???3.7 billion.

Who should attend?
?? Biotech and pharma industry executives, managers and scientists
?? Active investors (VC, brokers and advisors) in biotechnology companies
?? Academic researchers and managers
?? Proactive jobseekers, recruiters and head hunters
?? Suppliers and service providers to the bioscience industry
?? Potential Oxfordshire Bioscience Network members - come and find out more about us

How to register for the BioTuesday:
Contact Carla Betts including the delegate name, job title, email or phone 01865 594 644 to reserve your place at this event, or register online. As usual the meetings are free for delegates from biotech and healthcare companies, VCs and Business Angels, Academics, and ??42.50 + VAT to attend for everybody else.  There is sufficient free car parking at the venue.

How to get to BioTuesdays at Milton Park

Milton Park is a five minute drive from Didcot Parkway rail station, which is only 35 minutes from London Paddington by train.

There are regular buses from Didcot Parkway to Milton Park every 10 minutes until 18.30

There are taxi rank services available from Didcot Parkway, and the following are contact details of reputable private hire cabs in the area:
- Abbey Executive Travel - (01235) 820808
- Busby's Taxis - (01235) 555735
- Harold's Taxis - (01235) 512345
- Toot's Taxis - (01235) 555599
- LadyCars (Ladies & Children) - (07779) 760391
- Pryor's Taxis - (01235) 812345
- Star Cars of Didcot - (07702) 800999

Click here for a map of Milton Park of the immediate area around the venue, to help you find 43c.  The best way is to park near the centre of Milton Park near the white tent-like canvas which covers the municipal centre, cross the street at the traffic lights and turn left.
You can also ask for directions at the security lodge.
You can also find travel directions on the Milton Park website. 

Once you have registered, we will confirm your registration automatically by email, and you will receive a reminder email 24-48 hours before the event.
If you are liable to pay a registration fee, we will invoice you before the event.

In order that you can attend both OBN BioTuesday, and also the OION Medical

Devices and Diagnostics meeting taking place in nearby Abingdon on the same day, we have scheduled these events with sufficient time to travel between the two venues, with the OION event finishing by 7.30pm, and the OBN BioTuesday talks starting at 8.00pm.

The OION meeting is taking place 15 minutes' drive away from Milton Park at the Sophos building in nearby Abingdon.  To travel from the Sophos building, take the A415 (Ock Street) to the A34 and head south to the Milton Park exit (first exit).